Robert J. Hombach's most recent trade in Seaport Therapeutics Inc. was a trade of 12,258 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Seaport Therapeutics Inc | Robert J. Hombach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2026 | 12,258 | 12,258 | - | - | Stock Option (Right to Buy) | |
| Henry Schein | Robert J. Hombach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 2,577 | 5,421 (0%) | 0% | 0 | Common Stock par value $0.01 per share | |
| Biomarin pharma Inc - Registered Shares | Robert J. Hombach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 6,650 | 41,870 (0%) | 0% | 0 | Common Stock | |
| Henry Schein | Robert J. Hombach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 2,844 | 2,844 (0%) | 0% | 0 | Common Stock par value $0.01 per share | |
| Embecta Corp | Robert J. Hombach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 13,839 | 39,749 | - | 0 | Common Stock | |
| Biomarin pharma Inc - Registered Shares | Robert J. Hombach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 4,720 | 35,220 (0%) | 0% | 0 | Common Stock | |
| Embecta Corp | Robert Hombach J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 11,455 | 24,903 | - | 0 | Common Stock | |
| Biomarin pharma Inc - Registered Shares | Robert J. Hombach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 4,190 | 30,500 (0%) | 0% | 0 | Common Stock | |
| Biomarin pharma Inc - Registered Shares | Robert J. Hombach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 4,980 | 26,310 (0%) | 0% | 0 | Common Stock | |
| Embecta Corp | Robert J. Hombach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 6,024 | 6,024 | - | 0 | Common Stock | |
| CarMax | Robert J. Hombach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 1,308 | 7,766 (0%) | 0% | 0 | Common Stock | |
| Biomarin pharma Inc - Registered Shares | Robert J. Hombach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 5,120 | 21,330 (0%) | 0% | 0 | Common Stock |